- Home
- TFX vs CAI Comparison
TFX vs CAI Comparison
Compare TFX & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TFX | CAI |
|---|---|---|
| Founded | 1943 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1846 |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.0B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | TFX | CAI |
|---|---|---|
| Price | $130.43 | $17.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $138.75 | $30.91 |
| AVG Volume (30 Days) | 433.7K | ★ 2.8M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,992,713,000.00 | N/A |
| Revenue This Year | $15.97 | $25.24 |
| Revenue Next Year | $5.15 | $22.32 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $100.18 | $14.19 |
| 52 Week High | $139.67 | $42.50 |
Technical Indicators
Market Signals| Indicator | TFX | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 51.28 | 45.60 |
| Support Level | $119.28 | $14.19 |
| Resistance Level | $135.55 | $19.83 |
| Average True Range (ATR) | 3.74 | 1.16 |
| MACD | 0.58 | -0.10 |
| Stochastic Oscillator | 58.75 | 11.11 |
Price Performance
Historical ComparisonAbout TFX Teleflex Incorporated
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.